49 filings
8-K
AEON
AEON Biopharma Inc. - Ordinary Shares
16 May 24
Departure of Directors or Certain Officers
4:27pm
8-K
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
AEON Biopharma Reports First Quarter 2024 Financial Results
4:07pm
8-K
AEON
AEON Biopharma Inc. - Ordinary Shares
3 May 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:27pm
8-K
AEON
AEON Biopharma Inc. - Ordinary Shares
3 May 24
AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine
7:01am
8-K
AEON
AEON Biopharma Inc. - Ordinary Shares
17 Apr 24
Entry into a Material Definitive Agreement
4:06pm
8-K
7f8vkz9
15 Apr 24
Regulation FD Disclosure
4:16pm
8-K
a4caugd
29 Mar 24
AEON Biopharma Announces Redemption of Public Warrants
4:16pm
8-K
hu76qb
29 Mar 24
AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results
3:46pm
8-K
6y4pdnysitu52mxa
28 Mar 24
Entry into a Material Definitive Agreement
4:06pm
8-K
xbc7f0p4x
19 Mar 24
Entry into a Material Definitive Agreement
4:33pm
8-K
f3imiq3yo01k7mfx
16 Feb 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:10pm
8-K
kwhl4nvgkf7mg ws
13 Nov 23
AEON Biopharma Reports Third Quarter 2023 Financial Results
9:00am
8-K
3hvftr
19 Oct 23
AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine
4:23pm
8-K
okvawk28qcemazk
2 Oct 23
Changes in Registrant's Certifying Accountant
5:06pm
8-K/A
jzxop
11 Aug 23
Financial Statements and Exhibits
9:12pm
8-K
jhvxmws
27 Jul 23
Index to Financial Statements
5:28pm
8-K
vm81v0x84haevzc
24 Jul 23
Corporate Presentation July 2023
6:43am
8-K
o38e752tsa
17 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:18pm
8-K
l8zy1h41
11 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:09pm
8-K
z97 ak19r45n
5 Jul 23
Departure of Directors or Certain Officers
4:51pm